Is A Rise Imminent For Inovio Pharmaceuticals Stock After A Large 17% Fall In A Month

[Updated: Dec 16, 2021] INO Stock Decline

The stock price of Inovio Pharmaceuticals (NYSE: INO), a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, has seen a large fall of 17% over the last month, while it is down 8% over the last week. This can be attributed to the spread of the new Covid-19 variant – Omicron. Inovio is developing INO-4800 – its Covid-19 vaccine candidate, which is now in late stage clinical trials and it is still several months before it can hit the market, subject to regulatory approval. The investors were concerned if the vaccine will be useful against new variants, including Omicron. That said, the company stated that INO-4800 sparks T cell immune response, which are usually less vulnerable to viral mutations, implying it may do a better job in handling the new variants.

Now, there are several opinions being voiced for Omicron, some of them suggesting that its impact may be mild. WHO said that Omicron is likely to spread but it may cause milder disease compared to the Delta variant. ^[1] Furthermore, some studies have indicated that a booster shot from Moderna and Pfizer are likely to offer more protection from Omicron. ^[2] This again implies that Inovio may be too late in the vaccine race.

Given that INO stock is down 17% in a month, will it continue its downward trajectory, or is a rise imminent? Going by historical performance, there is a good chance of a rise in INO stock over the next month. Out of 412 instances in the last ten years that INO stock saw a twenty-one day fall of 17% or more, 269 of them resulted in INO stock rising over the subsequent one month period (twenty-one trading days). This historical pattern reflects 269 out of 412, or about 65% chance of a rise in INO stock over the coming month. See our analysis on Inovio Pharmaceuticals Stock Chance of A Rise for more details.

While INO stock may see higher levels going forward, it is helpful to see how its peers stack up. Check out Inovio Pharmaceuticals Stock Comparison With Peers to see how INO stock compares against peers on metrics that matter. You can find more such useful comparisons on Peer Comparisons.

[Updated: Oct 13, 2021] INO Stock Rise

The stock price of Inovio Pharmaceuticals (NYSE: INO), a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, reached its 52-week high levels of around $19 in February this year, before a large sell-off resulted in INO stock falling to levels of around $6 in April. This can be attributed to delays in trials for INO-4800, the company’s Covid-19 vaccine candidate. INO stock rallied back to levels of $10 in June before falling again to levels of around $7 currently, and much of this volatility this year can be attributed to the developments around its Covid-19 vaccine. Overall, the pessimism around the stock is due to a delay of its candidate in the Covid-19 vaccine race, where many countries have already seen a gradual rise in vaccination rate. 

Now, INO stock has seen a rise of 5.6% in a week (five trading days). The company recently reported that a booster shot of INO-4800 significantly increased the immune responses that resulted from the second dose. After seeing promising results from its phase three clinical trials, Inovio is seeking regulatory approval for its vaccine. But now that the INO stock has seen a 6% rise in a week, will it continue its upward trajectory or is a fall in INO stock imminent?

According to the Trefis Machine Learning Engine, which identifies trends in the company’s stock price using ten years of historical data, returns for INO stock average around 4.7% in the next one-month (twenty-one trading days) period after experiencing a 5.6% rise over the previous week (five trading days) implying that the stock will likely see higher levels in the near term. But how would the returns fare if you are interested in holding INO stock for a shorter or a longer time period? You can test the answer and many other combinations on the Trefis Machine Learning Engine to test Inovio Pharmaceuticals stock price forecast. You can test the chance of recovery over different time intervals of a quarter, month, or even just 1 day!

So, if this follows historical performance, it is likely that INO stock will rise to higher levels going forward. Also, Inovio Stock Return summarizes INO stock performance and chances of its rise or decline, among other metrics that matter. For additional details about Inovio Pharmaceuticals historical returns, and return comparison to peers see Inovio Pharmaceuticals (INO) Stock Return Comparison

Inovio Pharmaceuticals Stock Movements: Q&A with Trefis AI Engine

Q1: Is the price forecast for Inovio Pharmaceuticals stock higher after a drop?

Answer: Consider two situations,

Case 1: Inovio Pharmaceuticals stock drops by -5% or more in a week

Case 2: Inovio Pharmaceuticals stock rises by 5% or more in a week

Is the price forecast for Inovio Pharmaceuticals stock higher over the subsequent month after Case 1 or Case 2?

INO stock fares better after Case 1, with an expected return of 6.7% over the next month (21 trading days) under Case 1 (where the stock has just suffered a 5% loss over the previous week), versus, an expected return of 4.6% for Case 2. This implies a price forecast of $7.39 in Case 1 and a figure of $7.24 in Case 2 using INO market price of $6.92 on 10/12/2021.

In comparison, the S&P 500 has an expected return of 3.1% over the next 21 trading days under Case 1, and an expected return of just 0.5% for Case 2 as detailed in our dashboard that details the expected return for the S&P 500 after a rise or drop.

Try the Trefis machine learning engine above to see for yourself how the forecast for Inovio Pharmaceuticals stock is likely to changes after any specific gain or loss over a period.

Q2: Does patience pay?

Answer: If you buy and hold Inovio Pharmaceuticals stock, the expectation is over time the near-term fluctuations will cancel out, and the long-term positive trend will favor you – at least if the company is otherwise strong.

Overall, according to data and Trefis machine learning engine’s calculations, patience absolutely pays for most stocks!

For INO stock, the returns over the next N days after a -5% change over the last five trading days is detailed in the table below, along with the returns for the S&P500:

You can try the engine to see what this table looks like for Inovio Pharmaceuticals after a larger loss over the last week, month, or quarter.

Q3: What about the stock price forecast after a rise if you wait for a while?

Answer: The expected return after a rise is understandably lower than after a drop as detailed in Q1. Interestingly, though, if a stock has gained over the last few days, you would do better to avoid short-term bets for most stocks.

It’s pretty powerful to test the trend for yourself for Inovio Pharmaceuticals stock by changing the inputs in the charts above.

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since the end of 2016.

[1] Month-to-date and year-to-date as of 12/16/2021
[2] Cumulative total returns since 2017

1. WHO: Omicron could have ‘major impact’, but no definitive answers yet, UN News, Dec 8, 2021 [↩]
2. Current Covid boosters are enough to fight the omicron variant, Fauci says, Erika Edwards, NBC News, Dec 15, 2021 [↩]